Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Medicamen Organics IPO is a book built issue of Rs 10.54 crores. The issue is entirely a fresh issue of 31 lakh shares.
Medicamen Organics IPO bidding started from June 21, 2024 and ended on June 25, 2024. The allotment for Medicamen Organics IPO was finalized on Wednesday, June 26, 2024. The shares got listed on NSE SME on June 28, 2024.
Medicamen Organics IPO price band is set at ₹32 to ₹34 per share. The minimum lot size for an application is 4000 Shares. The minimum amount of investment required by retail investors is ₹136,000. The minimum lot size investment for HNI is 2 lots (8,000 shares) amounting to ₹272,000.
GYR Capital Advisors Private Limited is the book running lead manager of the Medicamen Organics IPO, while Kfin Technologies Limited is the registrar for the issue. The market maker for Medicamen Organics IPO is Giriraj Stock Broking.
Refer to Medicamen Organics IPO RHP for detailed information.
| IPO Date | June 21, 2024 to June 25, 2024 |
| Listing Date | June 28, 2024 |
| Face Value | ₹10 per share |
| Price Band | ₹32 to ₹34 per share |
| Lot Size | 4000 Shares |
| Total Issue Size | 3,100,000 shares (aggregating up to ₹10.54 Cr) |
| Fresh Issue | 3,100,000 shares (aggregating up to ₹10.54 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 8,600,000 |
| Share holding post issue | 11,700,000 |
| Market Maker portion | 172,000 shares Giriraj Stock Broking |
Medicamen Organics IPO offers 3,100,000 shares. 584,000 (18.84%) to QIB, 440,000 (14.19%) to NII, 1,028,000 (33.16%) to RII and 876,000 (28.26%) to Anchor investors.
| Investor Category | Shares Offered |
|---|---|
| Anchor Investor Shares Offered | 876,000 (28.26%) |
| Market Maker Shares Offered | 172,000 (5.55%) |
| QIB Shares Offered | 584,000 (18.84%) |
| NII (HNI) Shares Offered | 440,000 (14.19%) |
| Retail Shares Offered | 1,028,000 (33.16%) |
| Total Shares Offered | 3,100,000 (100%) |
Medicamen Organics IPO raises Rs 2.98 crore from anchor investors. Medicamen Organics IPO Anchor bid date is June 20, 2024. Medicamen Organics IPO Anchor Investors list
| Bid Date | June 20, 2024 |
| Shares Offered | 876,000 |
| Anchor Portion Size (In Cr.) | 2.98 |
| Anchor lock-in period end date for 50% shares (30 Days) | July 26, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | September 24, 2024 |
Medicamen Organics IPO opens on June 21, 2024, and closes on June 25, 2024.
| IPO Open Date | Friday, June 21, 2024 |
| IPO Close Date | Tuesday, June 25, 2024 |
| Basis of Allotment | Wednesday, June 26, 2024 |
| Initiation of Refunds | Thursday, June 27, 2024 |
| Credit of Shares to Demat | Thursday, June 27, 2024 |
| Listing Date | Friday, June 28, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on June 25, 2024 |
Investors can bid for a minimum of 4000 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 4000 | ₹136,000 |
| Retail (Max) | 1 | 4000 | ₹136,000 |
| HNI (Min) | 2 | 8,000 | ₹272,000 |
| Lot Size Calculator | |||
Mr. Bal Kishan Gupta is the promoter of the company.
| Share Holding Pre Issue | 81.21% |
| Share Holding Post Issue |
Medicamen Organics Limited was incorporated in 1995 and develops, manufactures, and distributes pharmaceutical dosages including generic dosages in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions and dry powders for the Government (including State Governments and Central Governments) and private entities as a contract manufacturer/third party manufacturer.
The company's product list comprises 84 products and offers a wide range of drugs such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, proton pump inhibitors, antihistamines, antihypertensive drugs, lipid preparations, antiparasitics, multivitamin preparations, multimineral and non-steroidal anti-inflammatory drugs (NSAIDS).
The company's products are marketed throughout India as well as in African, CIS, and South East Asian countries such as Congo, Benin, Kameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya through third-party distributors.
The company has two WHO-GMP-approved manufacturing facilities in Haridwar, Uttarakhand, covering an area of 21,536 Sq. Ft. As on September 30, 2023, the company has entered into contract manufacturing with 38 domestic partners and 12 merchant exporters.
As of September 30, 2023, the company employed a total of 116 people.
Medicamen Organics Limited's revenue increased by 10.13% and profit after tax (PAT) rose by 151% between the financial year ending with March 31, 2024 and March 31, 2023.
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 3,858.07 | 3,211.98 | 2,707.21 | 2,634.37 |
| Revenue | 2,528.96 | 2,296.24 | 2,118.67 | 2,505.96 |
| Profit After Tax | 240.41 | 95.78 | 9.23 | 29.81 |
| Net Worth | 1,518.40 | 851.71 | 755.92 | 746.72 |
| Reserves and Surplus | 658.40 | 251.71 | 155.92 | 146.72 |
| Total Borrowing | 1,265.65 | 1,179.50 | 1,024.57 | 958.97 |
| Amount in ₹ Lakhs | ||||
The market capitalization of Medicamen Organics IPO is Rs 39.78 Cr.
KPI as of March 31, 2024.
| KPI | Values |
|---|---|
| ROE | 19.90% |
| ROCE | 14.50% |
| Debt/Equity | 0.83 |
| RoNW | 15.83 |
| P/BV | 2.39 |
| PAT Margin (%) | 9.51 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 1.11 | 2.21 |
| P/E (x) | 30.53 | 15.41 |
The company proposes to utilize the Net Proceeds from the Issue towards the following objects:
[Dilip Davda] The company is operating in a highly competitive and fragmented segment of Pharma products. It posted average financial performance for the reported periods with boosted bottom line for FY24. Based on FY24 earnings, the issue appears fully priced. Well-informed investors may park moderate funds for the long term rewards. Read detail review...
The Medicamen Organics IPO is subscribed 993.56 times on June 25, 2024 6:19:56 PM. The public issue subscribed 1,309.77 times in the retail category, 173.03 times in the QIB category, and 1,343.83 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 173.03 |
| NII | 1,343.83 |
| Retail | 1,309.77 |
| Total | 993.56 |
Total Application : 336,611 (1,309.77 times)
| Listing Date | June 28, 2024 |
| BSE Script Code | |
| NSE Symbol | MEDIORG |
| ISIN | INE0PE401018 |
| Final Issue Price | ₹34 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| NSE SME |
|---|
| ₹34.00 |
| ₹137.85 |
| ₹130.95 |
| ₹144.70 |
| ₹144.70 |
Medicamen Organics Limited
10 Community Centre,
No 2 Ashok Vihar Phase II,
New Delhi, Delhi, 110052
Phone: +91-9818222845
Email: cs@mediorganics.in
Website: http://www.medicamenorganics.com/
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: medicamen.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
SME Company Owners
We could help you get listed on the stock market.
Check our SME IPO Guide 
Medicamen Organics IPO is a SME IPO of 3,100,000 equity shares of the face value of ₹10 aggregating up to ₹10.54 Crores. The issue is priced at ₹32 to ₹34 per share. The minimum order quantity is 4000 Shares.
The IPO opens on June 21, 2024, and closes on June 25, 2024.
Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Medicamen Organics IPO using UPI as a payment gateway. Zerodha customers can apply in Medicamen Organics IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Medicamen Organics IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Medicamen Organics IPO opens on June 21, 2024 and closes on June 25, 2024.
Medicamen Organics IPO lot size is 4000 Shares, and the minimum amount required is ₹136,000.
You can apply in Medicamen Organics IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Medicamen Organics IPO will be done on Wednesday, June 26, 2024, and the allotted shares will be credited to your demat account by Thursday, June 27, 2024. Check the Medicamen Organics IPO allotment status.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
